Reported effects Significant weight loss (10-15% body weight reduction) Improved glycemic control Reduced appetite and food intake Potential cardiovascular benefits Convenient once-weekly dosing Reported side effects Nausea, vomiting, diarrhea, constipation, abdominal pain (most common) Injection-site reactions (redness, swelling) Hypoglycemia risk (when combined with other medications) Rare reports of pancreatitis, gallbladder disease Storage Lyophilised (unmixed) Freeze at -20 C (-4 F) After reconstitution Refrigerate at 28 C (35.646.4 F)
Eligibility: Specific BMI requirements, age ranges, and health criteria
Local tissue repair plus systemic recovery in a single foundation healing peptide
Marketed as Mounjaro, the injectable drug is usually administered once a week
While they remain a solid choice, their pricing for tirzepatide is higher than newer competitors in the space
Ramachandran, K